Physician profile
John H Clancy
NPI 1962506238
$263.76
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $81.66 · 2021: $11.39 · 2022: $17.57.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $56.44 | 2019 | |
| Novo Nordisk INC | $49.34 | 2019-2020 | |
| Pfizer INC. | $42.17 | 2019-2020 | |
| Sanofi Pasteur INC. | $22.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $18.12 | 2019 | |
| Linus Health, INC. | $17.57 | 2022 | |
| Assertio Therapeutics, INC. | $16.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.53 | 2019 | |
| Boston Scientific Corporation | $14.27 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.39 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Clancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.